Fecal microbiota transplantation for refractory immune checkpoint inhibitor-associated colitis

被引:545
作者
Wang, Yinghong [1 ]
Wiesnoski, Diana H. [2 ]
Helmink, Beth A. [3 ]
Gopalakrishnan, Vancheswaran [3 ]
Choi, Kati [4 ]
DuPont, Hebert L. [5 ,6 ]
Jiang, Zhi-Dong [5 ]
Abu-Sbeih, Hamzah [1 ]
Sanchez, Christopher A. [2 ]
Chang, Chia-Chi [2 ]
Parra, Edwin R. [7 ]
Francisco-Cruz, Alejandro [7 ]
Raju, Gottumukkala S. [1 ]
Stroehlein, John R. [1 ]
Campbell, Matthew T. [8 ]
Gao, Jianjun [8 ]
Subudhi, Sumit K. [8 ]
Maru, Dipen M. [9 ]
Blando, Jorge M. [10 ]
Lazar, Alexander J. [9 ]
Allison, James P. [10 ]
Sharma, Padmanee [10 ]
Tetzlaff, Michael T. [7 ,9 ]
Wargo, Jennifer A. [2 ,3 ]
Jenq, Robert R. [2 ,11 ]
机构
[1] Univ Texas MD Anderson Canc Ctr, Dept Gastroenterol Hepatol & Nutr, Div Internal Med, Houston, TX 77030 USA
[2] Univ Texas MD Anderson Canc Ctr, Dept Genom Med, Div Canc Med, Houston, TX 77030 USA
[3] Univ Texas MD Anderson Canc Ctr, Div Surg, Dept Surg Oncol, Houston, TX 77030 USA
[4] Baylor Coll Med, Dept Internal Med, Houston, TX 77030 USA
[5] Univ Texas Houston, Ctr Infect Dis, Sch Publ Hlth, Houston, TX USA
[6] Kelsey Res Fdn, Houston, TX USA
[7] Univ Texas MD Anderson Canc Ctr, Dept Translat Mol Pathol, Div Pathol Lab Med, Houston, TX 77030 USA
[8] Univ Texas MD Anderson Canc Ctr, Dept Genitourinary Med Oncol, Div Canc Med, Houston, TX 77030 USA
[9] Univ Texas MD Anderson Canc Ctr, Dept Pathol, Div Pathol Lab Med, Houston, TX 77030 USA
[10] Univ Texas MD Anderson Canc Ctr, Dept Immunol, Div Basic Sci Res, Houston, TX 77030 USA
[11] Univ Texas MD Anderson Canc Ctr, Dept Stem Cell Transplantat, Div Canc Med, Houston, TX 77030 USA
基金
美国国家卫生研究院;
关键词
CYTOTOXIC T-CELLS; ADVERSE EVENTS; BLOCKADE; IMMUNOTHERAPY; IPILIMUMAB; CANCER;
D O I
10.1038/s41591-018-0238-9
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
We report the first case series of immune checkpoint inhibitors (ICI)-associated colitis successfully treated with fecal microbiota transplantation, with reconstitution of the gut microbiome and a relative increase in the proportion of regulatory T-cells within the colonic mucosa. These preliminary data provide evidence that modulation of the gut microbiome may abrogate ICI-associated colitis.
引用
收藏
页码:1804 / +
页数:7
相关论文
共 30 条
  • [1] Abu-Sbeih H., 2018, J IMMUNOTHER CANCER, V6, P1, DOI DOI 10.1186/S40425-018-0411-1
  • [2] Enterocolitis in patients with cancer after antibody blockade of cytotoxic T-lymphocyte-associated antigen 4
    Beck, Kimberly E.
    Blansfield, Joseph A.
    Tran, Khoi Q.
    Feldman, Andrew L.
    Hughes, Marybeth S.
    Royal, Richard E.
    Kammula, Udai S.
    Topalian, Suzanne L.
    Sherry, Richard M.
    Kleiner, David
    Quezado, Martha
    Lowy, Israel
    Yellin, Michael
    Rosenberg, Steven A.
    Yang, James C.
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2006, 24 (15) : 2283 - 2289
  • [3] Immune related adverse events associated with anti-CTLA-4 antibodies: systematic review and meta-analysis
    Bertrand, Anne
    Kostine, Marie
    Barnetche, Thomas
    Truchetet, Marie-Elise
    Schaeverbeke, Thierry
    [J]. BMC MEDICINE, 2015, 13
  • [4] Fecal microbiota transplantation and emerging applications
    Borody, Thomas J.
    Khoruts, Alexander
    [J]. NATURE REVIEWS GASTROENTEROLOGY & HEPATOLOGY, 2012, 9 (02) : 88 - 96
  • [5] Ultra-high-throughput microbial community analysis on the Illumina HiSeq and MiSeq platforms
    Caporaso, J. Gregory
    Lauber, Christian L.
    Walters, William A.
    Berg-Lyons, Donna
    Huntley, James
    Fierer, Noah
    Owens, Sarah M.
    Betley, Jason
    Fraser, Louise
    Bauer, Markus
    Gormley, Niall
    Gilbert, Jack A.
    Smith, Geoff
    Knight, Rob
    [J]. ISME JOURNAL, 2012, 6 (08) : 1621 - 1624
  • [6] QIIME allows analysis of high-throughput community sequencing data
    Caporaso, J. Gregory
    Kuczynski, Justin
    Stombaugh, Jesse
    Bittinger, Kyle
    Bushman, Frederic D.
    Costello, Elizabeth K.
    Fierer, Noah
    Pena, Antonio Gonzalez
    Goodrich, Julia K.
    Gordon, Jeffrey I.
    Huttley, Gavin A.
    Kelley, Scott T.
    Knights, Dan
    Koenig, Jeremy E.
    Ley, Ruth E.
    Lozupone, Catherine A.
    McDonald, Daniel
    Muegge, Brian D.
    Pirrung, Meg
    Reeder, Jens
    Sevinsky, Joel R.
    Tumbaugh, Peter J.
    Walters, William A.
    Widmann, Jeremy
    Yatsunenko, Tanya
    Zaneveld, Jesse
    Knight, Rob
    [J]. NATURE METHODS, 2010, 7 (05) : 335 - 336
  • [7] Baseline gut microbiota predicts clinical response and colitis in metastatic melanoma patients treated with ipilimumab
    Chaput, N.
    Lepage, P.
    Coutzac, C.
    Soularue, E.
    Le Roux, K.
    Monot, C.
    Boselli, L.
    Routier, E.
    Cassard, L.
    Collins, M.
    Vaysse, T.
    Marthey, L.
    Eggermont, A.
    Asvatourian, V.
    Lanoy, E.
    Mateus, C.
    Robert, C.
    Carbonnel, F.
    [J]. ANNALS OF ONCOLOGY, 2017, 28 (06) : 1368 - 1379
  • [8] Histopathologic Features of Colitis Due to Immunotherapy With Anti-PD-1 Antibodies
    Chen, Jonathan H.
    Pezhouh, Maryam K.
    Lauwers, Gregory Y.
    Masia, Ricard
    [J]. AMERICAN JOURNAL OF SURGICAL PATHOLOGY, 2017, 41 (05) : 643 - 654
  • [9] Gastrointestinal and Hepatic Complications of Immune Checkpoint Inhibitors
    Cramer P.
    Bresalier R.S.
    [J]. Current Gastroenterology Reports, 2017, 19 (1)
  • [10] Managing Adverse Events With Immune Checkpoint Agents
    Dadu, Ramona
    Zobniw, Chrystia
    Diab, Adi
    [J]. CANCER JOURNAL, 2016, 22 (02) : 121 - 129